Cochrane Abstracts
Ketamine and other NMDA receptor antagonists for chronic pain
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ketamine and Other NMDA Receptor Antagonists for Chronic Pain." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440387/all/Ketamine_and_other_NMDA_receptor_antagonists_for_chronic_pain.
Ketamine and other NMDA receptor antagonists for chronic pain. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440387/all/Ketamine_and_other_NMDA_receptor_antagonists_for_chronic_pain. Accessed March 21, 2025.
Ketamine and other NMDA receptor antagonists for chronic pain. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440387/all/Ketamine_and_other_NMDA_receptor_antagonists_for_chronic_pain
Ketamine and Other NMDA Receptor Antagonists for Chronic Pain [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440387/all/Ketamine_and_other_NMDA_receptor_antagonists_for_chronic_pain.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ketamine and other NMDA receptor antagonists for chronic pain
ID - 440387
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440387/all/Ketamine_and_other_NMDA_receptor_antagonists_for_chronic_pain
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
